Revium Rx (RVRC) Short-term Investments (2024 - 2026)

Revium Rx has disclosed Short-term Investments across 3 years of filings, most recently posting $664000.0 for Q2 2026.

• In Q2 2026, Short-term Investments changed N/A year-over-year to $664000.0; the TTM figure through Jun 2026 stood at $664000.0 (changed N/A YoY), while the FY2025 annual figure was $1.0 million, down 48.63% from the prior year.
• Short-term Investments came in at $664000.0 for Q2 2026 at Revium Rx, down from $1.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $2.0 million in Q4 2024 to a low of $664000.0 in Q2 2026.
• Average Short-term Investments over 3 years is $1.2 million, with a median of $1.0 million recorded in 2025.
• The largest YoY upside for Short-term Investments was 48.63% in 2025 against a maximum downside of 48.63% in 2025.
• Over 3 years, Short-term Investments stood at $2.0 million in 2024, then tumbled by 48.63% to $1.0 million in 2025, then sank by 35.72% to $664000.0 in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $664000.0 in Q2 2026, $1.0 million in Q4 2025, and $2.0 million in Q4 2024.